'Mouse Brains Appear to Eavesdrop on Their Fat' (The Scientist, September 2022)

The paper, 'Brain-Sparing Sympathofacilitators Mitigate Obesity without Adverse Cardiovascular Effects' has been featured in:

• Alan Morris (2020): Unravelling novel weight loss mechanisms. Nature Reviews Endocrinology.
• Jung Dae Kim and Sabrina Diano (2020): A Sympathetic Treatment for Obesity. Cell Metabolism.

The paper, 'Sympathetic neuron-associated macrophages contribute to obesity by importing and metabolizing norepinephrine' has been featured in:

• Stefan Jung: Year in Review — Macrophages and monocytes in 2017: Macrophages and monocytes: of tortoises and hares. Nature Reviews Immunology 2017 
• Conor A. Bradley (2017). Specialized macrophages contribute to obesity. Nature Reviews Endocrinology. 
• Making Fat Mice Lean: Novel Immune Cells Control Neurons Responsible For Fat Breakdown. ScienMag. 
• Wei Wong (14 Nov 2017). Fat expansion through norepinephrine catabolism. Editor's Choice, Science Signalling.
• Seth Thomas Scanlon (17 Nov 2017), Unusual macrophages contribute to obesity. Editor's Choice, Science 
• Guttenplan, Kevin A. et al. (2018) Play It Again, SAM: Macrophages Control Peripheral Fat Metabolism, Trends in Immunology 
• Michael P Czech (7 Nov 2017), Macrophages dispose of catecholamines in adipose tissue. Nature Medicine

The paper, 'Sympathetic neuro-adipose connections mediate leptin-driven lipolysis' has been featured in:

• Johan Ruud & Jens Bruening (2015). Metabolism: Light on leptin link to lipolysis. Nature
• Natasha Bray (2015). Zapping fat in WAT, Nature Reviews Neuroscience
• News and Views (2015).  A closer look at the nerves that slim down your fat cells, Science
• Luis Varela, Tamas L. Horvath (2015). A Sympathetic View on Fat by Leptin, Cell
• Qingchun Tong (2015) Exceptional F1000 Physiology, Technical Advance
• Mark Bothwell (2015) Very Good F1000 Neuroscience, New Finding

The first PhD student of the Domingos lab to graduate, Roksana Pirzgalska, has been featured in:

• Meet Roksana Pirzgalska - NIU Best Thesis Award Winner 2020

The second PhD student of the Domingos lab to graduate, Ines Mahu, has been featured in Cell Metabolism:

• Voices: The Author's Journey - I, Too, Belong in Science!

The Domingos laboratory researches neuroimmune mechanisms underlying obesity. They discovered neuro-adipose junctions, between white adipocytes and sympathetic neurons, that are necessary and sufficient for fat mass reduction via norepinephrine (NE) signalling. Moreover, they discovered Sympathetic neuron-Associated Macrophages (SAMs) that import and metabolize NE. Abrogation of SAM function promotes long-term amelioration of obesity independently of food intake. These findings inspired the development of a new class of anti-obesity compounds named sympathofacilitators, which do not enter the brain, nor have the typical cardiovascular side effects of centrally acting sympathomimetic drugs.  Sympathofacilitator drugs act as an energy sink by coupling thermogenesis to active heat dissipation. Ana Domingos is a member of the advisory board of Cell Metabolism and her lab has been funded by HHMI, Wellcome Trust, ERC, HFSP, EMBO, among others.

Ana speaks at IMMUNOGLOBAL  talks

^{© Global Immunotalks}

GRC, "Gordon Research Conference: Immune System in Health, Disease and Therapy", Castelldefels, Spain, Postponed.

Keystone Symposia, "Adipose Tissue: Energizing Good Fat / Bioenergetics in Health and Diseases", January 15-20 2023, Keystone, Colorado, USA.

Keystone Symposia - Neuroimmunometabolism - Obesity at the Crossroads between Neuroimmunity and Immunometabolism - Joint Meeting with Interconnection between the Gut, Brain and Microbiome for Metabolic Disease, October 07 - 10, 2022

ECRO- XXXI, 13-16 September 2021, Cascais, Portugal. View the Program on ECRO online.

EMBO Meeting - Neural control of metabolism and eating behaviour. Check out some pictures from the event.

BDI - MDO 2022, "Metabolic Diseases; Breakthrough Discoveries in Diabetes & Obesity", October 23-26 2022.

Neuroimmunometabolism, Icahn School of Medicine at Mount Sinai, Brain and Body Seminar series, October 5 2022.

Sidra Medicine's Precision Medicine and Functional Genomics 2022, "Neuroimmunometabolism", September 25 2022.

Complement UK, "Novel Mechanisms, Tools, and Therapies in Neuroinflammation", September 8-9 2022, King's College London. 

Cell Symposia, "Translational Immunometabolism", June 26-28 2022, Basel, Switzerland.

EMBO|FEBS Lecture Course, "Molecular mechanisms of interorgan crosstalk in health and disease", May 19-27 2022, Spetses, Greece.

Cell Symposia, "Metabolites in Signaling and Disease", April 3-5 2022, Lisbon, Portugal.

EMNO | EMBL Symposium, Inter-organ communication in physiology and disease, March 21-23 2022, online.

GRK1957, 3rd  Adipocyte-Brain Crosstalk Symposium, March 10-11 2022, online. Keynote Lecture.

Broad Institute of MIT and Harvard's 31st Center for the Study of Inflammatory Bowel Disease (CSIBD) Workshop and 2nd Broad Immunology Symposium, November 18 and November 19 2021

Nature Conference, “Metabolism in Health and Disease”, organised by Nature Cell Biology, Nature Metabolism and Nature Reviews Molecular Cell Biology, June 28-30, 2021.

Abcam Conference, "Immunometabolism: Fundamentals to Prospective New Therapies," June 8, 2021. Talk title "Sympathetic Neuroimmunometabolism"  View full programme.

Keystone eSymposia, Single Cell Biology, Wednesday 17 March 2021. Download the eSymposia program or view online here.

Keystone Symposia, Obesity: From Cell to Patient, February 1 -3 2021. See programme here.

Type 2 Immunity in Homeostasis and Disease - 21-22 February 2019